IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.933
EU - Europa 5.136
AS - Asia 1.530
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 1
SA - Sud America 1
Totale 14.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.913
UA - Ucraina 1.623
IE - Irlanda 811
DE - Germania 666
DK - Danimarca 625
SG - Singapore 600
SE - Svezia 512
TR - Turchia 412
IT - Italia 404
FI - Finlandia 329
KR - Corea 323
CN - Cina 185
MA - Marocco 105
GB - Regno Unito 76
EU - Europa 47
RU - Federazione Russa 44
CI - Costa d'Avorio 25
CA - Canada 20
FR - Francia 19
BE - Belgio 12
CZ - Repubblica Ceca 4
IN - India 4
AT - Austria 3
JP - Giappone 2
NL - Olanda 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
HK - Hong Kong 1
KZ - Kazakistan 1
LT - Lituania 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
VN - Vietnam 1
Totale 14.779
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.625
Fairfield 1.005
Dublin 811
Boardman 661
Wilmington 493
Ashburn 456
Woodbridge 406
Houston 373
Seattle 348
San Mateo 330
Lawrence 328
Princeton 328
Chandler 305
Cambridge 288
Centro 276
Singapore 230
Ann Arbor 164
San Diego 136
Des Moines 134
New York 132
Saint Petersburg 33
Abidjan 25
Beijing 23
Norwalk 21
Shanghai 21
London 19
Guangzhou 18
Brussels 12
Kilburn 12
Ottawa 11
Wuhan 10
Helsinki 8
Hounslow 8
Izmir 8
Dallas 6
Prescot 6
Toronto 6
Verona 6
Milan 5
Yiwu 5
Acton 4
Hanover 4
Jinhua 4
Olomouc 4
Pune 4
Rome 4
Shenzhen 4
Como 3
Hangzhou 3
Jiaxing 3
Mountain View 3
Palermo 3
Quanzhou 3
Strasbourg 3
Turin 3
Washington 3
Andover 2
Bari 2
Casalnuovo di Napoli 2
Chengdu 2
Chicago 2
Forest City 2
Frankfurt am Main 2
Gatchina 2
Kunshan 2
Los Angeles 2
Montréal 2
Pare 2
Perugia 2
Redmond 2
Redwood City 2
Serra Riccò 2
St Petersburg 2
Venice 2
Wandsworth 2
Zhengzhou 2
Alameda 1
Almaty 1
Ancona 1
Bagno A Ripoli 1
Bahawalpur 1
Barletta 1
Boulder 1
Cleveland 1
Contursi 1
Cupra Marittima 1
Cutrofiano 1
Falkenstein 1
Fidenza 1
Forlì 1
Hebei 1
Hong Kong 1
Islington 1
Jinan 1
Jiujiang 1
Kiev 1
Krimpen Aan Den Ijssel 1
Lerma 1
Linyi 1
Longyan 1
Totale 9.211
Salva come PNG Salva come JPEG
Nome #
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 97
Intraductal papillary mucinous neoplasms and chronic pancreatitis. 88
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 83
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival. 80
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 80
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 78
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. 76
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 76
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. 74
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. 73
B-Cell Lymphoma Presenting as Acute Pancreatitis. 73
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 73
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 72
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 72
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 72
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 72
Italian consensus guidelines for chronic pancreatitis 71
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. 71
A systematic review on robotic pancreaticoduodenectomy. 71
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 70
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 69
Enhanced recovery pathways in pancreatic surgery: State of the art 68
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. 67
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 67
Alchool intake,cigarette smoking and body mass index in patients with alcohol associated pancreatitis 65
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 65
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 65
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 64
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 64
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 64
Allelotype of pancreatic acinar cell carcinoma. 64
A preoperative score to predict early death after pancreatic cancer resection 64
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. 63
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 63
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. 62
Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study. 62
Current status of robotic distal pancreatectomy: a systematic review. 61
Re: "long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer" (Surg Endosc (2010) 24:1:63-67). 61
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides. 61
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 61
Neuroendocrine Tumor Disease- An Evolving Landscape. 60
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 60
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 60
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial 59
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 59
Anastomotic leakage in pancreatic surgery. 59
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography 59
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 58
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 58
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 58
Questions about branch-duct IPMNs with Sendai negative criteria. 58
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 58
Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry 58
Pancreas: Insulinoma--new insights into an old disease. 57
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System. Well-Differentiated Pancreatic Non-Functioning Tumors. 57
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. 57
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 57
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 57
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial 57
Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach. 57
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 57
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-asociated pancreatitis 57
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 56
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 56
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 56
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. 56
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 55
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 55
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 55
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. 55
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. 55
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. 55
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 55
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 55
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 54
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 54
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma 54
Extent of surgical resections for intraductal papillary mucinous neoplasms. 54
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 54
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 54
Minimally invasive necrosectomy versus conventional surgery in the treatment of infected pancreatic necrosis: a systematic review and a meta-analysis of comparative studies. 53
Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. 53
Laparoscopic ileocecal resection for bowel endometriosis. 52
Rectal indomethacin to prevent post-ERCP pancreatitis. 52
Enucleation of pancreatic neoplasms. 52
Pancreatic Pathology (Special Topics) 52
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study. 52
Autoimmune pancreatitis: a challenging diagnostic puzzle for clinicians. 52
Somatostatin analogs: is one better than other? 52
Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. 51
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? 51
The role of 18fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer. 51
Pancreatic enzyme replacement therapy after gastric resection: An update 51
Improving cytological diagnosis of pancreatic cysts: Is it clinically necessary or just the latest fashion? 50
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 50
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 50
Imaging of neuroendocrine gastroenteropancreatic tumours 50
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 50
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation. 50
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 50
Totale 6.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.173 0 0 0 0 0 0 339 0 327 11 6 490
2020/20214.237 194 530 522 77 616 272 378 307 395 331 400 215
2021/20222.074 123 565 12 93 3 179 78 149 116 209 51 496
2022/20231.886 367 189 228 61 56 120 2 32 736 3 49 43
2023/20241.386 328 7 32 349 325 145 18 9 1 8 4 160
2024/2025897 227 535 39 9 66 21 0 0 0 0 0 0
Totale 14.844